CD4 and neoplasm: Despite numerous conflicting reports on the impact of CD4 + Th1 cells on the survival outcomes of PDAC patients, mechanistically, these cells are linked with key cytokines IL-2, IFN-γ, and TNF-α, contributing to anti-tumor immunity [31].